ROCKVILLE, Md. & LANGENFELD, Germany & SHANGHAI & NAGOYA, Japan--(BUSINESS WIRE)--MEDIFACTS INTERNATIONAL, INC. a leading global cardiovascular core lab and SUZUKEN CO. Ltd – one of Japan’s largest cardiac safety services providers today announced the formation of a strategic alliance to deliver advanced technology and centralized cardiac safety testing services to the biopharmaceutical and medical device industry in Japan. Regarded as the world’s third largest geographic market for pharmaceutical development, companies in Japan now have access to leading cardiac safety monitoring technology and services for the management of their clinical trials.
